Deck 25: Lipid-Lowering Drugs and Atherosclerosis
Question
Question
Question
Unlock Deck
Sign up to unlock the cards in this deck!
Unlock Deck
Unlock Deck
1/3
Play
Full screen (f)
Deck 25: Lipid-Lowering Drugs and Atherosclerosis
When a patient is intolerant to statin class drugs, the most common second choice for treating LDL cholesterol levels greater than 135 mg/dl is:
A) Bile acid sequestrants
B) Fibric acid derivatives
C) Cholesterol absorption inhibitors
D) Niacin
E) Statins
A) Bile acid sequestrants
B) Fibric acid derivatives
C) Cholesterol absorption inhibitors
D) Niacin
E) Statins
Fibric acid derivatives
Isolated hypertriglyceridemia is best treated with:
A) Statins
B) Fibric acid derivatives
C) Cholesterol absorption inhibitors
D) Niacin
E) Bile acid sequestrants
A) Statins
B) Fibric acid derivatives
C) Cholesterol absorption inhibitors
D) Niacin
E) Bile acid sequestrants
Fibric acid derivatives
Vytorin is a combination of ezetimibe and simvastatin. The pharmacologic effects include:
A) Platelet inhibition
B) Reduction in intestinal absorption of cholesterol
C) Cholesterol-lowering ability independent of plasma lipoprotein levels
D) Inhibition in cholesterol synthesis within hepatocytes
E) A, B, and D
A) Platelet inhibition
B) Reduction in intestinal absorption of cholesterol
C) Cholesterol-lowering ability independent of plasma lipoprotein levels
D) Inhibition in cholesterol synthesis within hepatocytes
E) A, B, and D
A, B, and D

